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Background
Caseous lymphadenitis (CLA) has high relevance. It is a
chronic disease that affects sheep and goats. The causative
agent is Corynebacterium pseudotuberculosis, facultative
intracellular bacteria. The prevalence of caseous lympha-
denitis is high in many regions of the world, including
South America. Brazil has 78% of seroprevalence in goats
[1,2]. Therefore, prophylaxis becomes the best strategy as
an effective vaccine able to eradicate disease, but also to
formulate a serologic test able to detect visceral cases. One
of the first steps for developing of a serological test and an
effective vaccine is the choice of a target, which must pre-
sent appropriate antigenic characteristics. The CP40 pro-
tein (corynebacterial protease 40) have been studied in
several studies. This protease is considered one of the viru-
lence factors of C. pseudotuberculosis. Encoded by the
gene CP40 and characterized as a serine protease, proteins
responsible for several functions, such as providing the
activation of pro-inflammatory citocines which will help in
the activation of the immune response. However the aim
of this study was to evaluate the potential immune serine
protease recombinant in BALB/c mice.
Methods
To this end, CP40 protein was expressed in a heterologous
genes in a prokaryotic system and purified by nickel affi-
nity chromatography. The antigenicity of rCP40 was deter-
mined through positive and negative sera from animals for
LC by Western Blotting. To determine immunogenicity,
BALB / c mice were inoculated with a solution of rCP40,
saponin and Freund’s adjuvants in three doses on days 0,
15 and 30. The serum samples of these animals were
collected to check the production of specific antibodies
rCP40. Statistical analysis was performed using GraphPad
Prism version 6.0 for Windows (GraphPad Software, San
Diego, CA).
Results and conclusions
Positive sera reacted with the recombinant protein,
demonstrating that rCP40 maintained the antigenic prop-
erties, which is important because it demonstrates that
antibodies generated against the native protein present in
the bactéria C. pseutuberculosis were able to recognize the
recombinant protein. The results of the ELISA showed
that the development of humoral immune response was
generated by the experimental groups were inoculated
with rCP40 associated with both adjuvants. The activation
of helper T cells express ligands. Cytokines induce isotype
switching of immunoglobulins [3] which are fixed more
firmly to the antigens and plays diverse functions, forming
the most effective mediators of humoral response by invol-
ving the cellular immune system, including phagocytosis
and complement proteins. In mice the role of CD4 +
T-cells helper can provide production class antibody
IgG2a and IgG2B that are capable of promoting directly or
indirectly a response from Th1 and lead to opsonization
and toxicity mediated by cells [4].
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